Anesthetics promoting in vitro AβPP metabolism and amyloid-β toxicity

J Alzheimers Dis. 2010:22 Suppl 3:21-6. doi: 10.3233/JAD-2010-100984.

Abstract

At present, more than 35 million people worldwide have Alzheimer's disease (AD). With increasing incidence and a growing number of aged patients undergoing surgery, the relevance of a possible interaction between anesthetics and AD is growing as well. Below, we review in vitro studies investigating the effects of anesthetics on the metabolism of amyloid precursor protein and its metabolite amyloid-β.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / complications*
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Peptides / toxicity*
  • Amyloid beta-Protein Precursor / metabolism*
  • Anesthetics / adverse effects*
  • Animals
  • Humans

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Anesthetics